6ghk
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Human PARP1 (ARTD1) - Catalytic domain in complex with inhibitor ME0527== | |
- | + | <StructureSection load='6ghk' size='340' side='right'caption='[[6ghk]], [[Resolution|resolution]] 2.28Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[6ghk]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6GHK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6GHK FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EZ2:~{N}-[(1~{R})-1-(4-imidazol-1-ylphenyl)ethyl]-3-(4-oxidanylidene-1~{H}-quinazolin-2-yl)propanamide'>EZ2</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/NAD(+)_ADP-ribosyltransferase NAD(+) ADP-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.30 2.4.2.30] </span></td></tr> | |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ghk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ghk OCA], [http://pdbe.org/6ghk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ghk RCSB], [http://www.ebi.ac.uk/pdbsum/6ghk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ghk ProSAT]</span></td></tr> |
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/PARP1_HUMAN PARP1_HUMAN]] Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. Mediates the poly(ADP-ribosyl)ation of APLF and CHFR. Positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150. With EEF1A1 and TXK, forms a complex that acts as a T-helper 1 (Th1) cell-specific transcription factor and binds the promoter of IFN-gamma to directly regulate its transcription, and is thus involved importantly in Th1 cytokine production.<ref>PMID:17177976</ref> <ref>PMID:18172500</ref> <ref>PMID:19344625</ref> <ref>PMID:19661379</ref> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
[[Category: Brock, J]] | [[Category: Brock, J]] | ||
[[Category: Ekblad, T]] | [[Category: Ekblad, T]] | ||
- | [[Category: | + | [[Category: Elofsson, M]] |
+ | [[Category: Karlberg, T]] | ||
+ | [[Category: Lindgren, A E.G]] | ||
+ | [[Category: Moche, M]] | ||
[[Category: Schuler, H]] | [[Category: Schuler, H]] | ||
[[Category: Spjut, S]] | [[Category: Spjut, S]] | ||
- | [[Category: | + | [[Category: Thorsell, A G]] |
- | [[Category: | + | [[Category: Adp-ribosyl transferase]] |
- | [[Category: | + | [[Category: Inhibitor]] |
+ | [[Category: Protein-ligand complex]] | ||
+ | [[Category: Transferase]] |
Current revision
Human PARP1 (ARTD1) - Catalytic domain in complex with inhibitor ME0527
|